GlassScriptPhysician profile
Samuel W Adams
NPI 1972942134
$4,571.74
in general payments reported to CMS, 2019-2025
45 companies · $990 in 2025
The $990 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $150 · 2022: $705 · 2023: $922 · 2024: $797 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,708.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $569.88 | 2019-2025 | |
| Novo Nordisk INC | $500.05 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $464.72 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $340.69 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $329.25 | 2022-2025 | Freestyle Libre, Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $295.25 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $259.75 | 2019-2020 | |
| Amgen INC. | $186.07 | 2019-2025 | Repatha, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.43 | 2019-2025 | Jardiance |
| Medtronic, INC. | $136.27 | 2024-2025 | Interstim, Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $102.91 | 2022-2023 | |
| Dexcom, INC. | $98.40 | 2023-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.95 | 2019-2025 | Xifaxan, Relistor |
| Corium, LLC | $88.71 | 2022-2023 | Azstarys |
| Abbvie INC. | $78.19 | 2022-2024 | Qulipta, Vraylar |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.